Objective To investigate the treatment effects of Kansui root on severe acute pancreatitis (SAP) with abdominal compartment syndrome (ACS).Methods 16 cases of SAP were randomly divided into kansui root treatment group and control group according to random number table.Patients in control group received routine treatment including fasting, anti-shock, antibiotics and nutritional support.And the patients in kansui root group received routine treatment plus kansui root therapy.The clinical and laboratory parameters were determined and compared between the two groups.Results The relieving time of abdominal pain, bowel sound, the recovery time of hyperamylasemia, body temperature and leukocyte count in treatment group was (7.6±2.3)d, (6.1 ±3.1)d, (5.9±3.3)d, (5.2 ±3.2) d, (6.3 ±2.1)d, which were significantly shorter than those in control group [ ( 11.7 ± 2.1 ) d, ( 11.2 ± 2.3d, ( 10.2 ± 2.7) d, (9.2 ± 3.5 ) d, ( 11.1 ±3.3)d, P＜0.01 ) ].At the 3rd, 4th and 5th day, the intra-abdominal pressure in treatment group were also significantly lower than those in control group[ ( 19.8 ±3.1 )cmH2O vs(23.7 ±2.9) cmH2O, ( 12.3 ±2.7) cmH2O vs (21.3±1.5)cmH2O,(8.2±3.1)cmH2O vs (17.3 ±2.3)cmH2O,P＜0.05].Conclusions Severe acute pancreatitis has close relationship with Jiexiong syndrome in traditional chinese medicine.Kansui root is an effective therapy for alleviating high intra-abdominal pressure.

Objective To analyze the clinical efficacy of metacycline and rifampicin in the patients with refractory brucellosis,and to provide evidence for clinical treatment.Methods From February 2013 to February 2016,sixty-five patients diagnosed refractory brucellosis at the Department of Infectious Diseases,Weifang People's Hospital were enrolled in this study.They were randomly divided into two groups,treatment group (33 cases) and control group (32 cases).Patients of treatment group were treated with metacycline joint rifampicin,and control group was treated with doxycycline hyclate,rifampicin and levofloxacin.After treatment for six weeks,the clinical efficacy and adverse reactions were observed and data were analyzed.Results The effective rate in treatment group (96.97％,32/33) was significantly higher than that in control group (75.00％,24/32,x2 =4.86,P ＜ 0.05).The incidence of gastrointestinal reactions in control group (37.50％,12/32) was much higher than that in treatment group (15.15％,5/33,x2 =4.20,P ＜ 0.05).There were no significant differences between the two groups in the incidence of liver damage,skin rash and leukopenia (x2 =0.49,0.00,1.62,P ＞ 0.05).Conclusion The combined treatment metacycline and rifampicin is safe with high efficiency for patients with refractory brucellosis,and is worthy to be promoted.